fish oil – A two-year, randomized trial led by researchers at USC School of Medicine found that high-dose DHA supplements can reach the brain, but they did not improve memory or slow brain atrophy in older adults at elevated risk of Alzheimer’s disease.
For years. fish oil has sat quietly on pharmacy shelves with a promise that feels almost too good to ignore: help the brain stay sharp. and maybe even fend off dementia. In this new study. the first part of that story turns out to be true—docosahexaenoic acid. or DHA. reached the brain. But the second part, the part people actually want, didn’t budge at all.
USC School of Medicine researchers report results from a large, two-year clinical trial in older adults at elevated risk of developing Alzheimer’s disease. The takeaway is blunt. Even at high doses, DHA supplements did not improve memory or cognitive function and did not slow brain atrophy.
“Everyone hopes for a silver bullet to prevent Alzheimer’s disease. but we can’t say that fish oil supplements protect brain health. ” said Hussein Naji Yassine. director of the Personalized Brain Health Center at USC. “While omega-3s play an important role in forming brain cell connections needed for cognition. our results do not support fish oil supplements as a preventive measure against Alzheimer’s.”.
The trial enrolled 365 men and women aged 55 to 80 who rarely ate fish. Nearly half of them—47 percent—carried the APOE ε4 allele. described in the study as the strongest genetic risk factor for late-onset Alzheimer’s disease. Before the trial started, all participants consumed less than 200 mg of DHA per day through their diet.
Participants were randomly assigned to one of two groups for 24 months. One group took a daily supplement containing 2,000 mg of DHA. The other group received a placebo made from corn oil and soybean oil. designed to be indistinguishable from the DHA supplement in appearance. taste. and smell. Neither participants nor researchers knew who received which treatment.
The researchers had two questions to answer. First: does the supplement actually get where it’s supposed to go? Second: does it change anything about cognition or the early markers of Alzheimer’s?
On the first question, DHA cleared a key hurdle. Measurements of DHA levels in the cerebrospinal fluid—an area that surrounds the brain and spinal cord—showed concentrations increased by 17 percent after six months in the DHA group. The study also found no difference between carriers and noncarriers of the APOE ε4 allele. offering direct evidence that high-dose DHA supplementation reaches the brains of cognitively healthy older adults regardless of APOE ε4 status.
Then came the part that didn’t match the hope.
After 24 months, participants completed the Repeatable Battery for the Assessment of Neuropsychological Status, a standardized test of memory and cognitive performance. No significant differences appeared between the DHA and placebo groups.
Brain imaging told a similar story. There were no significant differences in changes in hippocampal volume, a brain region critical for memory and described as an early biomarker of Alzheimer’s disease.
The sequence matters: the supplement traveled to the brain, but the measurements stayed put—memory tests and hippocampal volume changes alike. That contrast is what makes the result land with such weight.
The research team points to several explanations for why DHA reached the brain yet failed to produce measurable clinical benefits. One possibility involves an enzyme that disrupts DHA metabolism in the brain. When an enzyme known as calcium-dependent phospholipase A2 (cPLA2) becomes activated. it may break down DHA before it can be incorporated into synaptic membranes. the structures where DHA is thought to play its most important role in supporting cognitive function.
Another possible explanation focuses on the participants themselves. Many had cardiovascular risk factors such as obesity, hypertension, and physical inactivity. The researchers say chronic inflammation associated with these conditions may have blunted the effects of supplementation. making it harder for a single nutrient to deliver measurable benefits.
They also note that the participants were relatively young for the study’s risk profile. with an average age of 66. and they experienced only minimal cognitive decline over the two-year period. If there isn’t much decline to slow down. the researchers suggest. it may simply have been too little change during the trial for DHA’s protective effect to show up.
This study doesn’t close the door on omega-3 biology. It closes a much more specific one: it doesn’t support the idea that fish oil supplements can serve as a preventive measure against Alzheimer’s disease in older adults who rarely eat fish and who are already at elevated risk.
USC School of Medicine DHA fish oil supplements Alzheimer's disease prevention randomized double-blind placebo-controlled trial cerebrospinal fluid hippocampal volume omega-3 APOE ε4 cPLA2 enzyme dementia risk
So basically it hit the brain and did nothing? fish oil is a scam then.
I always wondered why the gummies never worked for my grandma. Like, she took them for years and still got dementia. Not shocked.
Wait but it says DHA reached the brain, right? If it got there, shouldn’t it help?? Maybe it only helps people who already eat fish or who have that gene. I don’t have the patience for all this “it depends” stuff.
I hate when they say “silver bullet” like we’re supposed to believe that. Also 2,000 mg sounds like a lot but maybe it wasn’t enough? Or maybe Alzheimer’s is just in your DNA and no supplement can touch it. Either way I’m not paying for fish oil after reading this, even though my doctor keeps bringing it up.